Analyst Price Targets — IBRX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 4, 2026 12:54 pm | Edward Tenthoff | Piper Sandler | $12.00 | $9.20 | StreetInsider | Immunitybio Inc (IBRX) PT Raised to $12 at Piper Sandler |
| February 23, 2026 5:43 pm | — | H.C. Wainwright | $15.00 | $9.71 | TheFly | ImmunityBio price target raised to $15 from $10 at H.C. Wainwright |
| January 20, 2026 11:49 am | — | Piper Sandler | $7.00 | $5.52 | TheFly | ImmunityBio price target raised to $7 from $5 at Piper Sandler |
| January 10, 2025 11:49 am | Justin Zelin | BTIG | $6.00 | $2.42 | TheFly | ImmunityBio initiated with a Buy at BTIG |
| August 3, 2022 9:24 am | Kelly Shi | Jefferies | $8.00 | $4.13 | TheFly | Jefferies starts ImmunityBio at Buy on Anktiva potential, IO pipeline |
Latest News for IBRX
New class action for ImmunityBio (IBRX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/26/2026
New York, New York--(Newsfile Corp. - April 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and March 24, 2026, both dates inclusive (the "Class Period"), of the important May 26, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased ImmunityBio…
NEW YORK, April 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and March 24, 2026, both dates inclusive (the "Class Period"), of the important May 26, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
NEW YORK, April 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and March 24, 2026, both dates inclusive (the “Class Period”), of the important May 26, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
New York, New York--(Newsfile Corp. - April 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and March 24, 2026, both dates inclusive (the "Class Period"), of the important May 26, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased ImmunityBio…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for IBRX.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.